Recruiting Cardiomyopathy Studies in Baltimore
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
The main purpose of the study is to determine the changes in symptoms and functional limitations in participants with symptomatic hypertrophic cardiomyopathy (HCM) treated with sotagliflozin as compar...
Gene Therapy for ACM Due to a PKP2 Pathogenic Variant
This is a Phase 1/2, first-in-human, open-label, intravenous, dose-escalating, multicenter trial that is designed to assess the safety and tolerability of LX2020 in adult patients with PKP2-ACM...
About Cardiomyopathy Clinical Trials in Baltimore
Cardiomyopathy refers to diseases of the heart muscle that make it harder for the heart to pump blood. Types include dilated, hypertrophic, and restrictive cardiomyopathy. Treatment depends on the type and may include medications, devices, or heart transplant.
There are currently 2 cardiomyopathy clinical trials recruiting participants in Baltimore, MARYLAND. These studies are seeking a combined 510 participants. Research is being sponsored by Lexicon Pharmaceuticals, Lexeo Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Cardiomyopathy Clinical Trials in Baltimore — FAQ
Are there cardiomyopathy clinical trials in Baltimore?
Yes, there are 2 cardiomyopathy clinical trials currently recruiting in Baltimore, MARYLAND. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Baltimore?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.
Are clinical trials in Baltimore free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.
What cardiomyopathy treatments are being tested?
The 2 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for cardiomyopathy.
Data updated March 2, 2026 from ClinicalTrials.gov